Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ANAB

AnaptysBio

$86.07

0.49 (0.57%)

07:22
09/17/18
09/17
07:22
09/17/18
07:22
Recommendations
AnaptysBio analyst commentary at Cantor Fitzgerald »

Data on IL36R inhibitor…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ANAB

AnaptysBio

$85.58

0.37 (0.43%)

, REGN

Regeneron

$397.63

8.46 (2.17%)

16:21
09/13/18
09/13
16:21
09/13/18
16:21
Initiation
AnaptysBio, Regeneron, Sanofi initiated at Stifel »

AnaptysBio resumed with a…

ANAB

AnaptysBio

$85.58

0.37 (0.43%)

REGN

Regeneron

$397.63

8.46 (2.17%)

SNY

Sanofi

$44.39

1.05 (2.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Sep

  • 20

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Jan

  • 22

    Mar

  • 28

    Apr

  • 13

    May

ANAB

AnaptysBio

$88.63

0.03 (0.03%)

07:21
09/04/18
09/04
07:21
09/04/18
07:21
Recommendations
AnaptysBio analyst commentary at Cantor Fitzgerald »

AnaptysBio second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IIVI

II-VI

$49.65

1.1 (2.27%)

, CREE

Cree

$46.39

-0.87 (-1.84%)

10:25
08/28/18
08/28
10:25
08/28/18
10:25
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…

IIVI

II-VI

$49.65

1.1 (2.27%)

CREE

Cree

$46.39

-0.87 (-1.84%)

ARLO

Arlo Technologies

$22.15

-0.98 (-4.24%)

ANAB

AnaptysBio

$86.89

0.37 (0.43%)

OSK

Oshkosh

$71.44

0.17 (0.24%)

LASR

nLight

$29.73

-1.47 (-4.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Aug

  • 28

    Aug

  • 04

    Sep

  • 12

    Sep

  • 04

    Dec

  • 05

    Dec

ANAB

AnaptysBio

$86.31

0.16 (0.19%)

16:08
08/27/18
08/27
16:08
08/27/18
16:08
Initiation
AnaptysBio initiated at Cantor Fitzgerald »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
ANAB

AnaptysBio

$78.32

3.15 (4.19%)

06:59
08/07/18
08/07
06:59
08/07/18
06:59
Hot Stocks
AnaptysBio to deprioritize development of etokimab in peanut allergy »

AnaptysBio said in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

ANAB

AnaptysBio

$78.32

3.15 (4.19%)

06:58
08/07/18
08/07
06:58
08/07/18
06:58
Hot Stocks
AnaptysBio expects to report Phase 2a asthma data in Q3 »

AnaptysBio expects to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

ANAB

AnaptysBio

$78.32

3.15 (4.19%)

06:50
08/07/18
08/07
06:50
08/07/18
06:50
Hot Stocks
AnaptysBio see cash and equivalents enough through the end of FY19 »

AnaptysBio expects that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

ANAB

AnaptysBio

$78.32

3.15 (4.19%)

06:49
08/07/18
08/07
06:49
08/07/18
06:49
Earnings
AnaptysBio reports Q2 EPS (57c), consensus (70c) »

Reports Q2 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

ANAB

AnaptysBio

$76.01

3.11 (4.27%)

06:20
07/19/18
07/19
06:20
07/19/18
06:20
Initiation
AnaptysBio initiated at Credit Suisse »

AnaptysBio initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.